Cardiovascular Disease Risk Factors in HIV‐Infected Patients in the HAART Era
- 1 November 2001
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 946 (1) , 200-213
- https://doi.org/10.1111/j.1749-6632.2001.tb03913.x
Abstract
HIV infection is accompanied by disturbances in lipid and glucose metabolism, which are further compounded by changes induced by antiretroviral drugs. There is increasing concern that these changes will lead to an epidemic of cardiovascular disease. Cardiovascular disease will no doubt increase, but current data indicate that the average absolute levels are likely to remain low, although patients with additional risks (smoking, hypertension, diabetes, age, family history, etc.) are certainly more susceptible. The complications of therapy need to be taken into account when deciding on the time of treatment, and reducing risk factors should become a routine aspect of the care of an HIV population that now lives longer as a result of highly active antiretroviral therapy.Keywords
This publication has 81 references indexed in Scilit:
- Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and LipodystrophyClinical Infectious Diseases, 2001
- Adipose Redistribution in Human Immunodeficiency Virus–Seropositive Patients: Association with CD4 ResponseClinical Infectious Diseases, 2000
- Lipoatrophy, Fat Accumulation, and Mixed Syndrome in Protease Inhibitor???Naive HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Effect of Extracellular Human Immunodeficiency Virus Type 1 Glycoprotein 120 on Primary Human Vascular Endothelial Cell CulturesAIDS Research and Human Retroviruses, 1999
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophyThe Lancet, 1999
- RosiglitazoneDrugs, 1999
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged menThe American Journal of Cardiology, 1996
- Productive HIV‐1 infection of human vascular endothelial cells requires cell proliferation and is stimulated by combined treatment with interleukin‐1β plus tumor necrosis factor‐αJournal of Medical Virology, 1995
- Coronary artery lesions and human immunodeficiency virus infectionResearch in Virology, 1993